These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 142915)

  • 1. [Specific hepatotoxic effect of D-galactosamine].
    Andreicut S; Kerekes M
    Morphol Embryol (Bucur); 1977; 23(3):221-5. PubMed ID: 142915
    [No Abstract]   [Full Text] [Related]  

  • 2. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of partial hepatectomy on the hepatotoxicity of D-galactosamine.
    Andreicuţ S; Kerekes M
    Morphol Embryol (Bucur); 1982; 28(2):177-84. PubMed ID: 6213854
    [No Abstract]   [Full Text] [Related]  

  • 4. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
    James GW; Pickering RW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Galactosamine-hepatitis and anit-cholestasis. Liver damage caused by D-galactosamine-hydrochloride and 1-naphthyl-isothiocyanate (anit)].
    Leinweber B
    Fortschr Med; 1973 Jun; 91(18):792-6. PubMed ID: 4723864
    [No Abstract]   [Full Text] [Related]  

  • 6. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

  • 7. [Incorporation of 14-C-Glycine during galactosamine hepatitis of young and old rats (author's transl)a*].
    Platt D; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jul; 6(7):319-27. PubMed ID: 14537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural studies on D-galactosamine-HCl-induced liver injury in mice.
    Lapis K; Schaff Z
    Morphol Igazsagugyi Orv Sz; 1973 Aug; 13(4):276-88. PubMed ID: 4724880
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the behavior of microsomal enzymes in the rat liver following galactosamine administration].
    Leber HW; Leinweber B; Platt D
    Verh Dtsch Ges Inn Med; 1971; 77():1179-82. PubMed ID: 4346176
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current status of the study of mechanisms of liver injury caused by some commonly used hepatotoxic agents].
    Shen J
    Sheng Li Ke Xue Jin Zhan; 1990 Jan; 21(1):70-3. PubMed ID: 2193393
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipid metabolism and liver function in D-galactosamine poisoning in rats].
    Vengerovskiĭ AI; Saratikov AS
    Patol Fiziol Eksp Ter; 1988; (3):52-5. PubMed ID: 3174253
    [No Abstract]   [Full Text] [Related]  

  • 12. [Undesirable metabolic effects following the administration of larger doses of fructose and sorbitol].
    Bode JC
    Infusionstherapie (1973); 1974 Oct; 1(7):558-63. PubMed ID: 4219394
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relationship between lecithin-lysolecithin and cholesterol-cholesterol esters in the serum of the rat with galactosamine-induced hepatosis].
    Schriewer H; Rauen HM
    Experientia; 1972 Nov; 28(11):1324-5. PubMed ID: 4638905
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced D-galactosamine hepatotoxicity after propylthiouracil treatment in the rat.
    Mihas TA; Ceballos R; Hirschowitz BI; Gibson RG; Mihas AA
    J Med; 1982; 13(1-2):71-9. PubMed ID: 6956652
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of the hepatotoxic effects of D-galactosamine by D-galactose.
    Mészáros K; Antoni F; Hrabák A; Szikla C; Garzó T; Tompa A; Lapis K
    FEBS Lett; 1973 Sep; 35(1):1-3. PubMed ID: 4751995
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of galactosamine on the activity of lysosomal peptidehydrolases of the liver depending on the age of rats.
    Heissmeyer H; Stein U; Grub R; Reutter W; Lesch R
    Horm Metab Res; 1973 Mar; 5(2):93-7. PubMed ID: 4707707
    [No Abstract]   [Full Text] [Related]  

  • 17. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
    Reutter W; Bauer C; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
    [No Abstract]   [Full Text] [Related]  

  • 18. D-galactosamine induced hepatic cirrhosis: its ultrastructural and biochemical studies in rat.
    Funatsu K; Ishii H; Shigeta Y; Morita A; Tsuchiya M
    Acta Hepatogastroenterol (Stuttg); 1978 Apr; 25(2):97-104. PubMed ID: 654850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proceedings: Inhibition of autophagocytosis through cycloheximide in rat hepatocytes damaged by D-galactosamine].
    Rumpelt HJ; Albring M
    Verh Dtsch Ges Pathol; 1974; 58():522. PubMed ID: 4460541
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in polyamine metabolism of rat liver after administration of D-galactosamine. Favorable effects of putrescine administration on galactosamine-induced hepatic injury.
    Daikuhara Y; Tamada F; Takigawa M; Takeda Y; Mori Y
    Gastroenterology; 1979 Jul; 77(1):123-32. PubMed ID: 447009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.